These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 32530559)

  • 41. Viscosupplementation for the treatment of osteoarthritis of the knee.
    Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005321. PubMed ID: 15846754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Airborne nitric oxide: inflammatory marker and aerocrine messenger in man.
    Lundberg JO
    Acta Physiol Scand Suppl; 1996; 633():1-27. PubMed ID: 8876755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-Effectiveness of Treating Early to Moderate Stage Knee Osteoarthritis with Intra-articular Hyaluronic Acid Compared to Conservative Interventions.
    Rosen J; Niazi F; Dysart S
    Adv Ther; 2020 Jan; 37(1):344-352. PubMed ID: 31735982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled corticosteroids for cystic fibrosis.
    Balfour-Lynn IM; Welch K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD001915. PubMed ID: 25300165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled corticosteroids for cystic fibrosis.
    Dezateux C; Walters S; Balfour-Lynn I
    Cochrane Database Syst Rev; 2000; (2):CD001915. PubMed ID: 10796838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
    Bos AC; van Holsbeke C; de Backer JW; van Westreenen M; Janssens HM; Vos WG; Tiddens HA
    PLoS One; 2015; 10(3):e0118454. PubMed ID: 25734630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee.
    Altman RD; Bedi A; Karlsson J; Sancheti P; Schemitsch E
    Am J Sports Med; 2016 Aug; 44(8):2158-65. PubMed ID: 26578719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
    Ducharme FM; Hicks GC
    Cochrane Database Syst Rev; 2000; (3):CD002314. PubMed ID: 10908555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis.
    Pizzutto SJ; Upham JW; Yerkovich ST; Chang AB
    Cochrane Database Syst Rev; 2010 Apr; (4):CD007525. PubMed ID: 20393960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral steroids for long-term use in cystic fibrosis.
    Cheng K; Ashby D; Smyth RL
    Cochrane Database Syst Rev; 2011 Oct; (10):CD000407. PubMed ID: 21975730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.
    Ferreira ACM; Marson FAL; Cohen MA; Bertuzzo CS; Levy CE; Ribeiro AF; Ribeiro JD
    Lung; 2017 Aug; 195(4):431-439. PubMed ID: 28455785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of Hyaluronic Acid (HA) in Chronic Airway Diseases.
    Máiz Carro L; Martínez-García MA
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies.
    Xie B; Liu P; Wu Q; Xiang W
    Am J Emerg Med; 2020 Dec; 38(12):2713-2717. PubMed ID: 33046287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.